Laboratory testing for assessment of diabetes risk and glucose metabolism. Supports early identification of individuals at risk for type 2 diabetes.
Manufactured by
Labcorp
United States
Labcorp (NYSE: LH) is a global leader of innovative and comprehensive laboratory services that helps doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. The company provides insights and advances science to improve health and improve lives through unparalleled diagnostics and drug development laboratory capabilities. With nearly 71,000 employees serving clients in approximately 100 countries, Labcorp provided support for more than 85% of the new drugs and therapeutic products approved by the FDA in 2025 and performed more than 750 million tests for patients around the world. Learn more at www.labcorp.com.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Biomerica, Inc.
United States · 1 relevant product
Bio Preventive Medicine Co. Ltd.
Taiwan · 5 relevant products
Bioantibody Biotechnology Co., Ltd.
China · 2 relevant products
68 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →11 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 95 closest product alternatives
Biomerica, Inc. · United States
A diagnostic test for screening diabetes in at-home and clinical laboratory settings. Supports early detection of this high-prevalence chronic medical condition.
Bio Preventive Medicine Co. Ltd. · Taiwan
A predictive diagnostic test that evaluates the risk of progression to end-stage kidney disease in patients with diabetic kidney disease. The test identifies patients at high risk during the critical intervention window to prevent dialysis dependency.
Bioantibody Biotechnology Co., Ltd. · China
Quantitative test for blood glucose measurement and diabetes assessment. Supports metabolic disorder evaluation.
92 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products